SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-127672
Filing Date
2022-04-28
Accepted
2022-04-28 16:27:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d216794ddefa14a.htm DEFA14A 12068
2 GRAPHIC g216794g00a02.jpg GRAPHIC 326240
3 GRAPHIC g216794g00a03.jpg GRAPHIC 296981
  Complete submission text file 0001193125-22-127672.txt   871746
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36544 | Film No.: 22867107
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences